John Schreiber, MD, FAES

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Speaker
    Ineligible company: 
    Zogenix
    Topic: 
    fenfluramine for Dravet syndrome
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Neurocrine
    Topic: 
    SCN8A
Return to 2022 Epilepsy Board Review and Best Practices Course